Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Rumors

Rumors

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • M&A
  • News
  • Rumors

Amazon Among Bidders for Signify Health

By Charles Gross
August 21, 7:08 PM
-Wall Street Journal https://www.wsj.com/articles/amazon-among-bidders-for-signify-health-11661123042

AMZN

Read More
1 minute read
  • M&A
  • News
  • Rumors

Robinhood Lowered Its Offer to Acquire London-based Crypto Exchange Ziglu from $170M to $72.5M

By Charles Gross
August 19, 5:36 AM
-Blockworks https://blockworks.co/robinhood-slashes-offer-to-buy-crypto-exchange-ziglu-by-60/

HOOD

Read More
2 minute read
  • Cannabis
  • Global
  • Legal
  • Markets
  • News
  • Penny Stocks
  • Psychedelics
  • Rumors

Optimi Health Given Green Light To Produce And Distribute MDMA In Canada, The Legal Landscape Ahead

By Lara Goldstein
August 16, 4:36 PM
Optimi Health Corp.

OPTHF

Read More
1 minute read
  • Legal
  • News
  • Rumors

GeoVax To Be Issued U.S. Patent Titled ‘VACCINIA VIRAL VECTORS ENCODING CHIMERIC VIRUS LIKE PARTICLES’

By Benzinga Newsdesk
August 15, 10:45 AM
https://twitter.com/PatentGrants/status/1559189222061248514

GOVX

Read More
1 minute read
  • News
  • Rumors
  • Tech

EV Reported Sunday NIO Plans to Enter U.S. Market in 2025; Deploy First Battery Swap Station U.S. as Early as November 2022

By Charles Gross
August 15, 5:45 AM
https://eletric-vehicles.com/nio/exclusive-nio-to-enter-the-u-s-in-2025-first-battery-swap-station-arrives-in-november/

NIO

Read More
2 minute read
  • News
  • Rumors
  • Top Stories

Elon Musk Posts ‘Sex Tape’ Online: ‘Best. Clickbait. Ever.’

By Bibhu Pattnaik
August 13, 12:35 PM
Tesla Inc (NASDAQ: TSLA) CEO Elon Musk has taken Twitter by storm by sharing his "sex tape" tweet, sending his fans wild guesses. 

TSLA

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • General
  • Health Care
  • M&A
  • News
  • Rumors

Catalent-Repligen Merger ‘Seems Unlikely,’ This Analyst Says

By Vandana Singh
August 12, 6:30 PM
Yesterday, Catalent Inc (NYSE:CTLT) announced to acquire Metrics Contract Services for $475 million. Keybanc notes that the deal strengthens CTLT’s oral delivery…

CTLT

Read More
1 minute read
  • News
  • Rumors
  • Tech

Tesla Fremont Factory May Be Under Expansion

By Charles Gross
August 12, 4:45 PM
-Tesmanian https://www.tesmanian.com/blogs/tesmanian-blog/tesla-fremont-factory-may-be-under-expansion

TSLA

Read More
1 minute read
  • News
  • Rumors

‘Although some investors have recently worried that the mass production and shipment schedule of the iPhone 14 models may be affected by geopolitics, my latest survey indicates that there are currently no impacts on the supply chain…’ -Apple Analyst

By Benzinga Newsdesk
August 9, 11:37 AM
https://twitter.com/mingchikuo/status/1557028032237686784

AAPL

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • M&A
  • Movers
  • News
  • Rumors
  • Trading Ideas

Pfizer, Global Blood Therapeutics In Advanced Talks For $5B Buyout Deal: Report

By Vandana Singh
August 5, 12:20 PM
Pfizer Inc (NYSE: PFE) is reportedly in advanced talks to buy Global Blood Therapeutics Inc (NASDAQ: GBT) for about $5 billion, bolster its portfolio and pipeline.

GBT

Posts pagination

Previous 1 … 42 43 44 45 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service